Brendan Teehan

COO, Head of Commercial

COO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Acadia Pharmaceuticals Inc (ACAD)	Chief Operating Officer and Head of Commercial	$482,521	—	$517,472	$1,056,028	$225,641	$16,148	$2,297,810
2021	Acadia Pharmaceuticals Inc (ACAD)	Chief Operating Officer and Head of Commercial	$393,917	—	$1,765,002	$222,643	$48,065	$44,488	$2,474,115

Executive changes

Terminated Executive Vice President, Chief Operating Officer and Head of Commercial at Acadia Pharmaceuticals Inc (ACAD)
2024-11-18

Earnings-call appearances

Acadia Pharmaceuticals Inc Q3 FY2024 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2024-11-06
Acadia Pharmaceuticals Inc Q2 FY2024 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2024-08-06
Acadia Pharmaceuticals Inc Q1 FY2024 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2024-05-08
Acadia Pharmaceuticals Inc Q4 FY2023 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2024-02-27
Acadia Pharmaceuticals Inc Q3 FY2023 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2023-11-02
Acadia Pharmaceuticals Inc Q2 FY2023 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2023-07-18
Acadia Pharmaceuticals Inc Q1 FY2023 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2023-05-08
Acadia Pharmaceuticals Inc Q4 FY2022 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2023-02-28
Acadia Pharmaceuticals Inc Q3 FY2022 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-11-02
Acadia Pharmaceuticals Inc Q2 FY2022 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-08-08
Acadia Pharmaceuticals Inc Q1 FY2022 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-05-04
Acadia Pharmaceuticals Inc Q4 FY2021 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-02-28
Acadia Pharmaceuticals Inc Q3 FY2021 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2021-11-08